Belgium Pharmaceutical and Medical Goods Expenditure Share (2024)
Belgium's Pharmaceutical and Medical Goods Expenditure Share: 12.6 % of current health expenditure in 2024, +0.3pp YoY.
Belgium (2024)
12.6
% of current health expenditure
+0.3pp YoY
YoY Change
+0.3pp
percentage points
Trend
up
Series length
20
years of data
Data
| Year | % of current health expenditure | YoY Change |
|---|---|---|
| 2024 | 12.6 | +0.3pp |
| 2023 | 12.3 | +0.2pp |
| 2022 | 12.1 | +0.4pp |
| 2021 | 11.7 | -0.3pp |
| 2020 | 12 | -0.8pp |
| 2019 | 12.8 | +0.1pp |
| 2018 | 12.7 | -0.5pp |
| 2017 | 13.2 | -0.5pp |
| 2016 | 13.7 | -0.1pp |
| 2015 | 13.8 | -0.3pp |
| 2014 | 14.1 | -0.2pp |
| 2013 | 14.3 | -0.1pp |
| 2012 | 14.4 | -0.9pp |
| 2011 | 15.3 | -0.2pp |
| 2010 | 15.5 | -0.2pp |
| 2009 | 15.7 | -0.9pp |
| 2008 | 16.6 | -1.6pp |
| 2007 | 18.2 | +0.2pp |
| 2006 | 18 | -0.5pp |
| 2005 | 18.5 | n/a |
About this Dataset
Belgium recorded 12.6 % of current health expenditure in 2024. The latest change was +0.3pp. Across 2005–2024 the series ranges from 11.7 in 2021 to 18.5 in 2005.
This page tracks the share of current health expenditure devoted to pharmaceuticals and medical goods in Belgium.
Data sourced from Eurostat via SDMX REST API. Values use harmonised methodology intended for cross-country comparison.
Frequently Asked Questions
This page tracks the share of current health expenditure devoted to pharmaceuticals and medical goods in Belgium. It is published by Eurostat and updated annually.
The most recent observation covers 2024. Eurostat typically publishes this series with a lag of several months after the reference period. The series runs 2005–2024 (20 observations).
The series peaked at 18.5 % of current health expenditure in 2005 and reached its lowest recorded value of 11.7 in 2021. The latest reading of 12.6 in 2024 represents a change of +0.3pp.